Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries

Author： Wenger J.D.   DiFabio J.-L.   Landaverde J.M.   Levine O.S.   Gaafar T.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.7, 1999-11, pp. : 736-742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines

By Crowley-Luke A.   Reddin K.   Gorringe A.   Hudson M.J.   Robinson A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3399-3407

Elsevier

Access to resources Recommend Favorite

The introduction of new vaccines into developing countries

By Mahoney R.T.   Maynard J.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 646-652

Elsevier

Access to resources Recommend Favorite

The introduction of new vaccines into developing countries II. Vaccine financing

By Mahoney R.T.   Ramachandran S.   Xu Z.-Y.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2625-2635

Elsevier

Access to resources Recommend Favorite

Early immunization with conjugate vaccines

By Eskola J.   Kayhty H.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1433-1438

Elsevier

Access to resources Recommend Favorite

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

By Anttila M.   Eskola J.   &   9hman H.   Kayhty H.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1970-1977

Elsevier

Access to resources Recommend Favorite